We are committed to serving the best interests of our shareholders.

Filter Releases
Press Releases
Date Title and Summary View
5/26/2010 Boston, MA – May 26, 2010 – TESARO, Inc., an oncology-focused biopharmaceutical company, today announced that it has secured $60 million in start-up funding to acquire, develop and commercialize cancer therapeutics and supportive care products. Participants in a $20 million Series A financing included New Enterprise Associates (NEA) an...
= add release to Briefcase